These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21459825)

  • 1. Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration.
    Kruer MC; Hiken M; Gregory A; Malandrini A; Clark D; Hogarth P; Grafe M; Hayflick SJ; Woltjer RL
    Brain; 2011 Apr; 134(Pt 4):947-58. PubMed ID: 21459825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
    Hayflick SJ
    Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.
    Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.
    Neumann M; Adler S; Schlüter O; Kremmer E; Benecke R; Kretzschmar HA
    Acta Neuropathol; 2000 Nov; 100(5):568-74. PubMed ID: 11045680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
    Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
    AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallervorden-Spatz syndrome.
    Vakili S; Drew AL; Von Schuching S; Becker D; Zeman W
    Arch Neurol; 1977 Dec; 34(12):729-38. PubMed ID: 201232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
    Hayflick SJ; Westaway SK; Levinson B; Zhou B; Johnson MA; Ching KH; Gitschier J
    N Engl J Med; 2003 Jan; 348(1):33-40. PubMed ID: 12510040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).
    Haraguchi T; Terada S; Ishizu H; Yokota O; Yoshida H; Takeda N; Kishimoto Y; Katayama N; Takata H; Akagi M; Kuroda S; Ihara Y; Uchitomi Y
    Neuropathology; 2011 Oct; 31(5):531-9. PubMed ID: 21276079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
    Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y
    J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of neurodegeneration with brain iron accumulation.
    Gregory A; Hayflick SJ
    Curr Neurol Neurosci Rep; 2011 Jun; 11(3):254-61. PubMed ID: 21286947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
    Müller T; Amoiridis G; Kuhn W; Przuntek H
    Eur Neurol; 1999; 42(4):240-1. PubMed ID: 10567823
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease.
    Schaffert DA; Johnsen SD; Johnson PC; Drayer BP
    Neurology; 1989 Mar; 39(3):440-2. PubMed ID: 2927660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration with brain iron accumulation: A cautionary tale.
    Pearce JM
    Eur Neurol; 2006; 56(1):66-8. PubMed ID: 16921248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nosology of Hallervorden-spatz disease.
    Halliday W
    J Neurol Sci; 1995 Dec; 134 Suppl():84-91. PubMed ID: 8847549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.
    Álvarez-Córdoba M; Fernández Khoury A; Villanueva-Paz M; Gómez-Navarro C; Villalón-García I; Suárez-Rivero JM; Povea-Cabello S; de la Mata M; Cotán D; Talaverón-Rey M; Pérez-Pulido AJ; Salas JJ; Pérez-Villegas EM; Díaz-Quintana A; Armengol JA; Sánchez-Alcázar JA
    Mol Neurobiol; 2019 May; 56(5):3638-3656. PubMed ID: 30173408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.
    Woltjer RL; Reese LC; Richardson BE; Tran H; Green S; Pham T; Chalupsky M; Gabriel I; Light T; Sanford L; Jeong SY; Hamada J; Schwanemann LK; Rogers C; Gregory A; Hogarth P; Hayflick SJ
    Mol Genet Metab; 2015 Dec; 116(4):289-97. PubMed ID: 26547561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.
    Li A; Paudel R; Johnson R; Courtney R; Lees AJ; Holton JL; Hardy J; Revesz T; Houlden H
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):121-31. PubMed ID: 22416811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome.
    Hayflick SJ; Penzien JM; Michl W; Sharif UM; Rosman NP; Wheeler PG
    Pediatr Neurol; 2001 Aug; 25(2):166-9. PubMed ID: 11551748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.